{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T17:49:42Z","timestamp":1789148982247,"version":"build-2803163510"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T00:00:00Z","timestamp":1742169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T00:00:00Z","timestamp":1742169600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"DOI":"10.1007\/s00403-025-04088-z","type":"journal-article","created":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T09:39:55Z","timestamp":1742204395000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Therapy resistant hypertrophic lichen planus and its response to oral tofacitinib with a priori tissue cytokine expression: a real-world hospital-based study"],"prefix":"10.1007","volume":"317","author":[{"given":"Savitha","family":"Sharath","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1757-3406","authenticated-orcid":false,"given":"Kabir","family":"Sardana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ananta","family":"Khurana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Apeksha","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Archana","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,17]]},"reference":[{"key":"4088_CR1","doi-asserted-by":"publisher","first-page":"3098","DOI":"10.1080\/09546634.2022.2116926","volume":"33","author":"A Motamed-Sanaye","year":"2022","unstructured":"Motamed-Sanaye A, Khazaee YF, Shokrgozar M, Alishahi M, Ahramiyanpour N, Amani M (2022) JAK inhibitors in lichen planus: a review of pathogenesis and treatments. J Dermatolog Treat 33:3098\u20133103","journal-title":"J Dermatolog Treat"},{"key":"4088_CR2","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1046\/j.1365-4362.2003.01791.x","volume":"42","author":"A Campanati","year":"2003","unstructured":"Campanati A, Marconi B, Penna L, Giangiacomi M, Offidani A (2003) A case of hypertrophic lichen ruber planus of the leg complicated by a squamous cell carcinoma. Int J Dermatol 42:415\u2013416","journal-title":"Int J Dermatol"},{"key":"4088_CR3","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1177\/12034754231156100","volume":"27","author":"A Abduelmula","year":"2023","unstructured":"Abduelmula A, Bagit A, Mufti A, Yeung KCY, Yeung J (2023) The use of Janus kinase inhibitors for lichen planus: an Evidence-Based review. J Cutan Med Surg 27:271\u2013276","journal-title":"J Cutan Med Surg"},{"key":"4088_CR4","doi-asserted-by":"publisher","first-page":"3475","DOI":"10.1002\/eji.201444891","volume":"44","author":"S Eyerich","year":"2014","unstructured":"Eyerich S, Zielinski CE (2014) Defining Th-cell subsets in a classical and tissue-specific manner: examples from the skin. Eur J Immunol 44:3475\u20133483","journal-title":"Eur J Immunol"},{"key":"4088_CR5","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1016\/j.jid.2018.02.034","volume":"138","author":"F Lauffer","year":"2018","unstructured":"Lauffer F, Jargosch M, Krause L, Garzorz-Stark N, Franz R, Roenneberg S et al (2018) Type I immune response induces keratinocyte necroptosis and is associated with interface dermatitis. J Invest Dermatol 138:1785\u20131794","journal-title":"J Invest Dermatol"},{"key":"4088_CR6","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1111\/exd.14226","volume":"30","author":"K Pietschke","year":"2021","unstructured":"Pietschke K, Holstein J, Meier K, Sch\u00e4fer I, M\u00fcller-Hermelink E, Gonzalez-Menendez I et al (2021) The inflammation in cutaneous lichen planus is dominated by IFN-\u03d2 and IL-21-A basis for therapeutic JAK1 Inhibition. Exp Dermatol 30:262\u2013270","journal-title":"Exp Dermatol"},{"key":"4088_CR7","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/s41392-023-01471-y","volume":"8","author":"L Sun","year":"2023","unstructured":"Sun L, Su Y, Jiao A, Wang X, Zhang B (2023) T cells in health and disease. Signal Transduct Target Ther 8:235","journal-title":"Signal Transduct Target Ther"},{"key":"4088_CR8","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1016\/j.jaci.2020.01.031","volume":"145","author":"W Damsky","year":"2020","unstructured":"Damsky W, Wang A, Olamiju B, Peterson D, Galan A, King B (2020) Treatment of severe lichen planus with the JAK inhibitor Tofacitinib. J Allergy Clin Immunol 145:1708\u20131710e2","journal-title":"J Allergy Clin Immunol"},{"key":"4088_CR9","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.jdcr.2023.04.017","volume":"37","author":"S Youssef","year":"2023","unstructured":"Youssef S, Bordone LA (2023) Oral Tofacitinib effectively treating eruptive and hypertrophic cutaneous lichen planus. JAAD Case Rep 37:16\u201320","journal-title":"JAAD Case Rep"},{"key":"4088_CR10","doi-asserted-by":"publisher","first-page":"adv00220","DOI":"10.2340\/00015555-3585","volume":"100","author":"P Seiringer","year":"2020","unstructured":"Seiringer P, Lauffer F, Pilz AC, Boehmer D, Biedermann T, Eyerich K (2020) Tofacitinib in hypertrophic lichen planus. Acta Derm Venereol 100:adv00220","journal-title":"Acta Derm Venereol"},{"key":"4088_CR11","doi-asserted-by":"publisher","first-page":"2955","DOI":"10.1007\/s00403-023-02707-1","volume":"315","author":"K Sardana","year":"2023","unstructured":"Sardana K, Sharath S, Khurana A (2023) Use of Tofacitinib in recalcitrant cases of chronic pruritus of unknown origin. Arch Dermatol Res 315:2955\u20132957","journal-title":"Arch Dermatol Res"},{"key":"4088_CR12","doi-asserted-by":"publisher","first-page":"e12824","DOI":"10.1111\/dth.12824","volume":"32","author":"P Arora","year":"2019","unstructured":"Arora P, Sardana K, Gautam RK, Malhotra P (2019) Low dose thalidomide monotherapy for the treatment of recalcitrant erosive lichen planus. Dermatol Ther 32:e12824","journal-title":"Dermatol Ther"},{"key":"4088_CR13","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1111\/ced.14015","volume":"45","author":"K Sardana","year":"2020","unstructured":"Sardana K, Gupta A, Sinha S (2020) An observational analysis of low-dose thalidomide in recalcitrant prurigo nodularis. Clin Exp Dermatol 45:92\u201396","journal-title":"Clin Exp Dermatol"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-025-04088-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00403-025-04088-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-025-04088-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T09:39:57Z","timestamp":1742204397000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00403-025-04088-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,17]]},"references-count":13,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4088"],"URL":"https:\/\/doi.org\/10.1007\/s00403-025-04088-z","relation":{},"ISSN":["1432-069X"],"issn-type":[{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,17]]},"assertion":[{"value":"9 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"590"}}